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Abstract: Scrapie is an infective ovine neurodegenerative disease; the only identified component 
of the infectious agent being an aberrant isoform (PrPSc) of the cellular prion protein (PrPC). So far, 
no means for ante-mortem diagnosis are available for Scrapie as well as for any other mammal 
Transmissible Spongiform Encephalopaties. We recently found a strong relationship between cell 
susceptibility  to  scrapie-infection  and  intracellular  cholesterol  homeostasis  alterations.  In  brain 
tissues as well as in ex vivo cultures of skin fibroblasts  and PBMCs from healthy and scrapie-
affected sheep carrying a scrapie-susceptible (ARQ/ARQ) genotype, the levels of cholesterol esters 
were consistently higher than in tissues and cultures derived from animals with a scrapie-resistant 
(ARR/ARR) genotype. Moreover, both  uninfected and scrapie-affected ARQ/ARQ sheep showed 
abnormally  low  levels  of  high  density  lipoprotein-cholesterol  (HDL-C)  in  their  plasma,  as 
compared to ARR/ARR animals. We now show that intracellular accumulation of cholesterol esters 
in fibroblasts derived from scrapie-susceptible sheep was accompanied by parallel alterations in the 
expression level of genes and gene products (ACAT1 and Cav-1) that are involved in the pathways 
leading  to  intracellular  cholesterol  esterification  and  trafficking.  Comparative  analysis  of  PrPc 
mRNA, showed an higher expression level  in cells from animals carrying susceptible genotype, 
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with or without Scrapie. Preliminary experiments also revealed the presence of  PK-resistant PrP 
isoforms in the latter cultures. The data reported in the present paper suggest that accumulation of 
cholesterol  esters  in  peripheral  cells,  together  with  the  altered  expression  of  some  proteins 
implicated  in  intracellular  cholesterol  homeostasis,  might  serve  to  identify  a  distinctive  lipid 
metabolic  profile  associated  with  increased  susceptibility  to  develop  prion  disease  following 
infection.
Key words: Scrapie, Prion diseases, Cholesterol homeostasis, Cholesterol esters.
*Equal contribution.
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Introduction
Prion diseases are fatal neurodegenerative disorders for which no “in vitam” diagnostic tests nor 
effective  treatments  are  currently  available.  Prion  diseases  can  be  inherited,  sporadic  or 
transmissible,  but in spite of their  diverse origin,  all  these forms seem caused by the structural 
conversion of the cellular  prion protein (PrPc) into its pathologic and infective isoform (PrPsc)(1). 
PrPc is normally GPI-anchored to specialized cholesterol-rich domains of the plasma membrane, 
termed  lipid  rafts  or  caveolae(2).  These  membrane  domains  are  detergent-insoluble  regions 
characterized by the presence of free cholesterol  (FC), saturated phospholipids and raft-resident 
proteins  (3).  Increasing evidence indicates that  subtle  intracellular  cholesterol  changes  affect  the 
intracellular  processing/trafficking,  function and/or  activation of raft-resident  proteins,  including 
PrP (4,5). Therefore, a role for cholesterol in the metabolism of PrPc and its conversion into PrPSc 
has been proposed (5-7).
In normal tissues,  approximately 90% of the total  cellular  cholesterol resides in membrane raft 
domains as FC, while only a minor amount (approximately 1-10%) is found as cholesterol esters 
(CE)  in  a  cytoplasmic  storage  form  (8).  Because  membrane  cholesterol  appears  critical  for  the 
function  of  raft-resident  proteins,  cells  developed  a  highly  integrated  set  of  homeostatic 
mechanisms that finely regulate FC vs. CE pools according to the cell’s need. In fact, membrane FC 
is in a dynamic state, moving to the ER in response to changing homeostatic conditions in the cell 
(9,10)
. FC in the ER, if in excess, is converted to CE by the acyl-cholesterol-acyl-transferase (ACAT), 
and  stored  in  the  cytoplasm as  neutral  lipid  droplets  (11).  When  cell  needs  FC  for  membrane 
function, or when CE droplets exceed a critical threshold value, CE can be reconverted to FC and 
recycled to the membrane by cholesterol binding proteins, such as caveolin-1 (Cav-1)(3,4). 
Our  recent  studies(12,13) on  the  role  of  cholesterol  homeostasis  in  the  pathogenesis  of  Scrapie, 
revealed abnormal accumulation of CE in the brains and in ex vivo peripheral blood mononuclear 
cells  (PBMCs) and skin  fibroblast  cultures  from healthy  and scrapie-affected sheep  carrying  a 
scrapie-susceptible genotype, when compared to those of sheep with resistant genotype. Similar 
alterations  were  observed  in  mouse  neuroblastoma  cell  lines  persistently  infected  with  mouse-
adapted 22L and RML strains of scrapie that showed up to 3-fold higher CE levels than parental 
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N2a  cells(13).  Moreover,  i)  scrapie-like  prion  protein  (PrPres)-producing  cell  populations  of 
subclones  from  scrapie-infected  cell  lines  were  characterized  by  higher  CE  levels  than  clone 
populations not producing PrPres, and ii) drugs interfering with cholesterol metabolism associated 
reduction of CEs to PrPres inhibition(14). We thus suggested that abnormal CE levels could identify 
a phenotype predisposing a cell to the development of pathologic processes involving abnormal 
activation, and/or processing, and/or trafficking of membrane resident proteins.
In an attempt to better characterize the lipid metabolic state that appears to influence the genetic 
susceptibility to Scrapie, in the present study we compared gene and protein expression of ACAT1, 
Cav-1, and PrPc in brains and skin fibroblasts from Sarda breed sheep carrying scrapie-resistant 
(ARR/ARR) or  scrapie-susceptible  (ARQ/ARQ) genotype,  both without  (ARQ/ARQ-) and with 
(ARQ/ARQ+)  Scrapie.  In  addition,  the  correlation  between  expression  of  ACAT-1  and  Cav-1 
proteins with that of PrPres was evaluated in skin fibroblast cultures from sheep with the different 
genotypes.
Results
ACAT-1 protein levels in sheep brains. Due to the role of ACAT-1 in the conversion of FC into 
CE,  we investigated whether  the different  CE levels,  previously  observed  in  brains  of  scrapie-
resistant  and scrapie-susceptible  sheep(12),  correlated  with the  expression  of  this  enzyme.  Thus, 
Western  blot  analysis  of  brain  protein  extracts  of  ARR/ARR  (scrapie-infected;  scrapie-free), 
ARQ/ARQ- (mock infected) and ARQ/ARQ+ (scrapie-infected; scrapie-affected) sheep was carried 
out using the anti-ACAT-1 H-125 monoclonal  antibody.  As shown in Fig.  1,  lower  expression 
levels of ACAT-1 enzyme were indeed detected in the brains of ARR/ARR sheep, with respect to 
those of ARQ/ARQ- and ARQ/ARQ+ animals. When compared to sheep with ARR/ARR genotype, 
ARQ/ARQ- and ARQ/ARQ+ sheep showed 1.7 and 2-fold higher levels of ACAT-1, respectively.
PrPc and Cav-1 mRNA levels  in  sheep brains. Based on the knowledge that  PrPc  is  a  raft-
resident protein(2,5), and that Cav-1(3,4) is involved in FC trafficking, we next measured mRNA levels 
of  PrPc  and  Cav-1  in  brain  homogenates  of  scrapie-susceptible  and  scrapie-resistant  sheep. 
Unfortunately,  ACAT-1 mRNA levels could not be evaluated because the sequence of the ovine 
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ACAT gene is not available. As shown in Fig. 2, lower levels of PrPc mRNA, and higher levels of 
Cav-1  mRNA,  were  detected  in  ARR/ARR  sheep  brains  as  compared  to  ARQ/ARQ- and 
ARQ/ARQ+ animals.
ACAT-1 and Cav-1 protein levels in quiescent and replicating sheep skin fibroblasts.  Since 
alterations  in  cholesterol  homeostasis  were  also  found  in  peripheral  cells(12,13),  we  investigated 
whether  similar  expression  patterns  of  ACAT-1 and Cav-1  differentiated  skin  fibroblasts  from 
sheep with different genetic susceptibility to Scrapie. Due to the fact that cholesterol homeostasis is 
differently modulated during cell growth(15), the expression level of the two proteins was analysed at 
various time points after growth stimulation with FCS.  Western blot analysis (Fig. 3), confirmed 
that,  consistently  with  the  results  obtained  in  brains,  quiescent  (time  0)  ARR/ARR fibroblasts 
contained remarkably lower ACAT-1 expression than ARQ/ARQ fibroblasts (Panel A). Following 
FCS stimulation, the above differences in ACAT-1 expression became less prominent,  with the 
exception of ARQ/ARQ- fibroblasts  at 24 hrs.  On the contrary,  ARR/ARR quiescent fibroblasts 
showed remarkably higher Cav-1 expression than ARQ/ARQ fibroblasts (Panel B). Also in this 
case, the above differences became less dramatic 24 hrs after FCS stimulation, and were further 
reduced at 48 and 72 hr time points. In summary, scrapie-susceptible animals exhibit higher levels 
of ACAT-1 protein in both fibroblasts and brains. By contrast, significantly lower amounts of Cav-
1 protein expression, particularly at 0 time and 72 hrs after growth stimulation, characterized the 
scrapie-susceptible sheep fibroblasts. 
Cav-1 and PrPc mRNA levels in quiescent and replicating sheep skin fibroblasts. As shown in 
Fig. 4, with respect to ARR/ARR fibroblasts, ARQ/ARQ cultures associated basal (time 0) lower 
mRNA levels of Cav-1 to higher mRNA levels of PrPc. Following FCS stimulation, the differences 
between scrapie-susceptible and scrapie-resistant sheep in the Cav-1 and PrPc mRNAs diminished 
or disappeared at 24 and 48 hrs, to reappear at the 72 hr time point. The significantly higher PrPc 
mRNA level detected in both brains and fibroblasts from scrapie-susceptible animals, prompted us 
to evaluate whether the presence of the scrapie-like PrP protein (PK-resistant PrP) could be detected 
in the ARQ/ARQ fibroblast cultures. Interestingly, Western blot analysis of PrP in extracts of 72 hr 
FCS-stimulated  fibroblasts  from  the  scrapie-susceptible  sheep  (Fig.5),  whether  or  not  scrapie-
infected,  revealed  the  presence  of  PK-resistant  bands.  No PK-resistant  bands were  detected  in 
5
C Na
tu
re
 P
re
ce
di
ng
s 
: h
dl
:1
01
01
/n
pr
e.
20
07
.1
21
1.
1 
: P
os
te
d 
8 
O
ct
 2
00
7
ARR/ARR lysates (Fig. 5). Although the PK-resistant bands could be detected loading extremely 
high amounts of protein (140 g total protein), and although two set of fibroblast cultures fromμ  
sheep with the different genotypes were so far evaluated, these results confirm that sheep carrying 
ARQ/ARQ genotype is more prone to spontaneous PrP structural conversion than those carrying 
ARR/ARR genotype. This result fit with the higher expression of PrPc mRNA observed in brains 
(Fig. 2) and fibroblasts (Fig. 5) from scrapie-susceptible sheep, and may justify a more consistent 
PrPSc formation following infection with Scrapie. 
Discussion
PrPSc  is  generally  thought  to  represent  the  infectious  agent  of  Scrapie,  through  its  ability  to 
promote  the  structural  conversion  of  the  normal  cellular  prion  protein  PrPc  into  a  likeness  of 
itself(16) . Although the existence of genetic susceptibility to scrapie infection is well documented(17-
18),
, how particular metabolic states of target cells could modulate the degree of this susceptibility 
are not entirely clear. In this context, our previous studies on the role of alterations of intracellular 
cholesterol  homeostasis in the pathogenesis  of Scrapie in  sheep,  revealed a  positive correlation 
between an abnormal  accumulation  of  cholesterol  esters  (CE) and the genetic  susceptibility  to 
infection(12-14). Of particular relevance, these alterations were found not only in brains but also in 
peripheral tissues, such as cultured skin fibroblasts and PBMCs, from the scrapie-susceptible sheep 
(ARQ/ARQ genotype). In the present  study, we found that cellular  cholesterol  alterations  were 
accompanied by parallel alterations in the expression levels of genes and gene products, ACAT1 
and  Cav-1,  involved  in  the  pathways  leading  to  intracellular  cholesterol  esterification  and 
trafficking.  In  particular,  higher  ACAT1  and  lower  Cav-1  expression  characterized  cells  with 
scrapie-susceptible  genotype.  Interestingly,  in  fibroblasts  carrying  the  susceptible  ARQ/ARQ 
genotype, we also found that mRNA expression of PrPc was higher than in cultures from scrapie-
resistant sheep, and that PK-digestion led to detectable PK-resistant PrP isoforms. These data lead 
to suggest that genetic PrP polymorphisms and alterations of cholesterol homeostasis may act in 
concert to create an environment favorable to the initiation and progression of prion disease. Our 
conclusions  are  sustained  by  recent  evidences  indicating  that the  metabolic  fate  of  PrPc is 
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dependent on its location at the plasma membrane(19,20), which in turn is mediated by cholesterol 
levels in the raft domains (21), suggesting that the conversion rate of PrPc into PrPsc may be, at least 
partly, dependent on cholesterol homeostatic regulatory mechanisms. In fact, rafts seem essential 
for the proper folding of nascent PrPc protein and cholesterol depletion in membranes promotes the 
conversion of PrPc into PrPsc(21,22). On the other hand, replication of misfolded PrP protein was 
reported to interfere with raft composition by displacing raft proteins, such as Cav-1, likely leading 
to alterations of intracellular cholesterol trafficking and accumulation(23). 
In  summary,  further  studies  are  necessary  to  elucidate  the  mechanisms  responsible  for  the 
cholesterol  homeostasis  alterations  in  sheep  carrying  a  genotype susceptible  to  scrapie,  and  to 
unveil possible cause-effect relationships between PrP polymorphisms and cholesterol alterations. 
Similarly, additional work is needed to reveal the potential implication of this association for prion 
disease susceptibility. Nonetheless, the data reported in the present paper suggest that accumulation 
of  cholesterol  esters  in  peripheral  cells,  together  with  the  altered  expression  of  some proteins 
implicated  in  intracellular  cholesterol  homeostasis,  might  serve  to  identify  a  distinctive  lipid 
metabolic  profile  (PCT/IT2007/000109;  PCT/IT2007/000110) associated  with  increased 
susceptibility to develop prion disease following infection. 
Materials and Methods
Brain and skin samples. All samples were provided by Dr. Ciriaco Ligios and were collected at 
the experimental farms of the Istituto Zooprofilattico Sperimentale of Sardinia, Italy. Brain samples 
were collected from 3 adult sheep: two sheep carried the susceptible scrapie genotype ARQ/ARQ, 1 
sheep was clinically affected by natural  scrapie (ARQ/ARQ+) while the other  was healthy and 
negative  for  PrPSc in  the  brain  (ARQ/ARQ-);  the  third  sheep  carried  the  resistant  genotype 
ARR/ARR. All sheep were euthanized with a barbiturate followed by 4 ml of embutramide and 
mebenzonico-iodide (Hoechst Roussel Vet), brain samples were stored at –80°C immediately after 
collection and thawed just prior to use. Fresh skin biopsies were obtained from 14 sheep and were 
delivered to our laboratory in transport medium (Eurocollins). Ten biopsies were from sheep with 
the susceptible genotype ARQ/ARQ; of these, 2 were scrapie-free (ARQ/ARQ-), while 7 developed 
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clinical  disease  following  experimental  inoculation  of  scrapie  and  1  had  natural  scrapie 
(ARQ/ARQ+). In addition,  skin biopsies from 4 scrapie-resistant ARR/ARR sheep, which were 
experimentally infected with scrapie and remained free of clinical signs, were used as controls. All 
biopsies were taken at the terminal clinical stage of the scrapie-affected sheep. All animals were 
raised in the same environmental conditions and were of the same age and sex in order to reduce 
physiological differences of biochemical and molecular determinations. 
Skin fibroblast cultures. Tissues fragments from skin biopsies were plated into 6-well plates and 
allowed to adhere to the bottom of the vessels. After 2 hrs, they were covered with a few drops of 
Dulbecco’s modified Eagle’s medium (D-MEM) (Gibco Lab NY, USA) supplemented with 10% 
fetal bovine serum (FBS) (Sigma), 100 U/ml penicillin/streptomycin (Sigma), and fungizone (Life 
Technologies, Inc.) and incubated at 37°C in a humidified incubator with 5% CO2. The following 
day, tissue fragments were overlaid with culture medium, which was changed every two days. Five 
to six days later, fibroblasts begun to proliferate from the fragment margins (“halo of cells”) and to 
form a monolayer. After four weeks, fibroblasts were purified by repeated trypsinization (trypsin-
EDTA) and passaging to achieve an homogenous population of spindle cells. Purified fibroblasts 
were washed twice with sterile PBS and centrifuged. 1x106 cells were then seeded into 25 cm2 
culture flask and grown to confluence. Then, cells were either used for “in vitro” experiments or 
resuspended  in  cryopreservation  medium  at  a  density  of  1x107 cells/ml  and  stored  in  liquid 
nitrogen. Analytical assays were carried out using fibroblast cultures between the second and fourth 
passage.  Cells  were  plated  at  a  density  of  5x103 cell/cm2 in  6-well  plates  and  brought  to 
proliferative quiescence by incubation for 48 hrs in serum depleted (0.2% FCS) MEM 199. Then, 
quiescent cells were stimulated to re-enter cell cycle by addition of 10% FCS and incubation at 37 
°C for the indicated time intervals.
RT-PCR and Southern blotting. The expression levels of Cav-1 and PrPc mRNAs were evaluated 
in brain homogenates and skin fibroblasts by reverse transcription polymerase chain reaction (RT-
PCR). mRNA levels for the housekeeping gene β-actin were used to normalize the amount of RNA 
inputs in the RT-PCR. Total RNA was extracted from 106  cells using TRIZOL reagent (Invitrogen 
Corporation). Equal amounts of total RNA (1  µg) were reverse transcribed into cDNA using the 
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random hexamer method and amplified by PCR in the presence of specific primers, according to the 
instructions provided by the manufacturer (GeneAmp RNA PCR Kit, Perkin-Elmer Cetus). 
PCR was performed using the following ovine-specific primers and conditions: for Cav-1 (258 bp) 
forward: 5’- GATTAACAGTGGGTACGATA-3’, reverse: 5’-TATGTAGTCTTGCGTTATCC-3’; 
94 °C for 30 sec, 59 °C for 30 sec and 72 °C for 45 sec, for 30 cycles. For PrP, (341 bp.) forward: 
5’-ATTGTCACCTAGCAGATAGA-3’, reverse: 5’-TTGTTCAGTAGCTCAAGTCT-3’; 94 °C for 
30  sec,  58°C for  1  min,  and  72  °C for  45  sec,  for  30  cycles.  For  β-actin  (217 bp)  forward: 
5’-GATCATGTTTGAGACCTTC-3’, reverse:  5’-GAGGATCTTCATGAGGTAGT-3’; 96 °C for 
30 sec,  60 °C for  59 sec, and 72 °C for  45 sec,  for 20 cycles.  Sub-saturation levels of cDNA 
templates, needed to produce a dose-dependent amount of PCR product,  were defined in initial 
experiments by testing a range of template concentrations.  Amplicons were labeled during PCR 
with Digoxigenin-11-dUTP (DIG; Roche Applied Science), immuno-detected with anti-digoxigenin 
antibodies conjugated to alkaline phosphatase (Roche Applied Science) and visualized with the 
chemiluminescent substrate CSPD®. The intensity of the autoradiographic bands was measured 
after exposure to X-ray film with the Kodak Digital Science Band Scanner Image Analysis System 
containing HP ScanJet,  ID Image Analysis Software.  The overall  procedure was normalized by 
expressing  the amount of PCR products  for  each target  mRNA relative  to the amount of PCR 
products obtained for the housekeeping gene β-actin.
Western blotting. Proteins were extracted from brain homogenates and fibroblast monolayers with 
the RIPA buffer (0.05 mL per mg tissue or cell pellets from 106 fibroblasts). Protein concentration 
was determined with the Bicinchoninic Acid Protein determination kit (Sigma). For ACAT1 and 
Cav-1, aliquots of protein extracts were separated by 10% SDS polyacrylamide gel electrophoresis 
and  blotted  onto  nitrocellulose  membranes  (Millipore,  Bedford  MA).  Blots  were  subjected  to 
immunoblotting  with  a  1:5000  dilution  of  the  anti-ACAT-1  antibody  (H-125,  Santa  Cruz 
Biotechnology, Santa Cruz,  CA) and a 1:2000 dilution of the anti-Cav-1 antibody (7C8, Novus 
Biologicals,  Littleton CO),  as  indicated by the manufacturer.  Blots  were  then reacted  with the 
appropriate dilution of a HRP-conjugated secondary antibody (1:6500 for ACAT-1 and 1: 1000 for 
Cav-1). Specific bands were detected after addition of the chemiluminescent substrate (Amersham, 
Freiburg  Germany),  and  analyzed  by  the  NIH Image  1.63  Analysis  Software  program  (Scion 
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Image). For PrP, samples were digested or not with 20 μg/ml PK (Novagen, USA) in TBS (ratio 
PK:total protein, 1:900) at 37°C for 30 min, and digestion was stopped by incubating with 4 mM 
Pefabloc (Roche, Novagen, USA) for 10 min on ice. Samples of 140μg protein were loaded onto a 
10% NuPage bis-tris-polyacrylamide gel (Invitrogen, USA) just after boiling, and blotted onto a 
PVDF membrane (Millipore, Bedford MA). The membrane was blocked with 5% (wt/vol) non-fat 
dry milk (Bio Rad, USA) and 0.05% (vol/vol) Tween 20 (USB corporation; USA) in TBS (TBS-T-
milk) for 60 min at room temperature. The PVDF was then incubated with a 1:20000 dilution of the 
anti-PrP  antibody 6H4 (Prionics Zurich)  that  recognizes  a  sequence  conserved  in  most  known 
mammal  PrP sequences  (human,  cattle,  sheep and others)  in  TBS-T,  and then  with a  1:50000 
dilution of the horseradish peroxidase labeled anti-mouse IgG antibody (GE Healthcare,  UK) in 
TBS-T, as indicated by the manufacturer.  After extensive washings, membrane was soaked for 5 
min  in  ECL-plus  reagent  (GE  Healthcare),  and  exposed  to  x-ray  film  (Hyperfilm  ECL,  GE 
Healthcare). Autoradiography films were captured in TIFF format.
Statistical analysis. Data are reported as mean ± standard error (SE). Statistical calculations were 
performed using the statistical analysis software of Origin 7.0 version (Microcal, Inc, Northampton,
MA, USA). A value of P<0.05 was considered to be statistically significant. 
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Figure 1. ACAT-1 protein expression in brain extracts of  sheep carrying scrapie-resistant (ARR/ARR) or 
scrapie-susceptible (ARQ/ARQ) genotypes, with (ARQ/ARQ+) or without (ARQ/ARQ-) clinical Scrapie. 
Proteins  were extracted,  separated by PAGE and subjected to Western blot as indicated in Materials and 
Methods. Panel (A) shows representative autoradiograms of Western blot of ACAT-1 and β-actin, used as an 
internal control. Panel (B) shows densitometric analyses of the ACAT-1 bands shown in panel A, normalized 
for the endogenous β-actin protein content. Data represent mean values ± SE of triplicate determinations of 
four samples from each brain. * P <0.05 vs ARR/ARR
Figure  2. PrPc  and  Cav-1  mRNA  expression  in  brain  extracts  of  sheep carrying  scrapie-resistant 
(ARR/ARR) or  scrapie-susceptible (ARQ/ARQ) genotypes, with (ARQ/ARQ+) or  without  (ARQ/ARQ-) 
clinical Scrapie. Panel (A) shows representative autoradiograms of RT-PCR of PrPc and Cav-1 mRNAs 
expression (see Materials an Methods). Panel B shows densitometric analyses of the PrPc and Cav-1 bands 
shown in  panel  A,  normalized  for  the  endogenous  β-actin  mRNA content  that  was used as  an internal 
control. Data represent mean values ± SE of triplicate determinations of four samples from each brain.* P 
<0.05 vs ARR/ARR
Figure 3. ACAT-1 and Cav-1 protein expression in cultured skin fibroblasts from sheep carrying scrapie-
resistant  (ARR/ARR)  or  scrapie-susceptible  (ARQ/ARQ)  genotypes,  with  (ARQ/ARQ+)  or  without 
(ARQ/ARQ-) clinical Scrapie. Western blot analysis were performed as described (Material and Methods) at 
the time of growth stimulation with FCS (0 hr) or 24, 48 and 72 hrs later. The upper parts of panels A and B 
show representative autoradiograms of Western blots for ACAT-1 and Cav-1 (B), respectively. The bottom 
parts show densitometric analysis of ACAT-1 (A) and Cav-1 (B) bands, normalized for the endogenous β-
actin  protein  content.  Bars  indicate  mean values  ± SE of  skin  fibroblast  samples  from 4 ARR/ARR, 4 
ARQ/ARQ- and 6 ARQ/ARQ+ sheep. * (p<0.05) vs ARR/ARR sheep.
Figure 4. PrPc and Cav-1 mRNA levels in cultured skin fibroblasts from sheep  carrying scrapie-resistant 
(ARR/ARR) or  scrapie-susceptible (ARQ/ARQ) genotypes, with (ARQ/ARQ+) or  without  (ARQ/ARQ-) 
clinical Scrapie. Analysis were performed at the time of growth stimulation with FCS (0 hr) or 24, 48 and 72 
hrs later. The upper parts of panels A and B shows representative autoradiograms of RT-PCR analysis for 
PrPc and Cav-1, respectively. The bottom parts shows densitometric analysis of autoradiographic bands for 
PrPc (A) and Cav-1 (B) mRNA, normalized for the β-actin mRNA contents. Bars indicate mean values ± SE 
of  skin  fibroblast  samples  from  4  ARR/ARR,  2  ARQ/ARQ-  and  8  ARQ/ARQ+  sheep.  *  p<0.05  vs 
ARR/ARR sheep.
13
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
21
1.
1 
: P
os
te
d 
8 
O
ct
 2
00
7
Figure 5. PrPc and PK-resistant PrP (PrPres) profiles of cultured skin fibroblasts carrying scrapie-resistant 
(ARR/ARR) or  scrapie-susceptible (ARQ/ARQ) genotypes, with (ARQ/ARQ+) or  without  (ARQ/ARQ-) 
clinical  Scrapie.  Lysates  of  72hr  FCS-stimulated  cultures  from  1  ARR/ARR,  1  ARQ/ARQ+  and  1 
ARQ/ARQ- sheep, were treated or not with 20 μg/ml PK (ratio 1:900), and analysed by Western blot 
procedure with 6H4 antiserum. 
14
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
21
1.
1 
: P
os
te
d 
8 
O
ct
 2
00
7
Figure 1
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Figure 3
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